English
April 25, 2026
Every year, more than 100,000 Americans undergo thyroid surgery. The majority leave the operating room with a horizontal scar at the base of their neck—a mark they will carry for the rest of their lives. What very few of those patients are told, often because their surgeon has never been trained in the alternative, is that a significant proportion of them did not need that scar.
Remote-access "scarless" thyroid surgery—a family of techniques that reroutes the entire operation away from the neck—has matured from an experimental novelty into a proven, guideline-supported approach offered at a small number of centers worldwide with the volume and expertise to do it safely. At the Russell Center for Endocrine Health, it is now our default approach for appropriately selected patients. This article tells you exactly who those patients are.
The term "scarless" refers to the absence of any visible incision on the front of the neck. The most widely validated remote-access technique is called TOETVA—Transoral Endoscopic Thyroidectomy Vestibular Approach. Instead of cutting across the neck, the surgeon works through three tiny incisions (5 mm on each side, approximately 10 mm centrally) placed entirely inside the lower lip, in the space between the gums and the inner surface of the lip. The incisions are completely hidden. They heal without visible marks. The neck itself is never cut.
A second family of techniques, including the retroauricular and axillary approaches, routes the surgery behind the ear or through the armpit. At the Russell Center, we select among approaches based on each patient's anatomy, diagnosis, and goals—but TOETVA remains our workhorse, and the only technique that leaves no visible scar anywhere on the body.
Candidacy is determined by a combination of anatomical factors, diagnosis, and—critically—the surgeon's experience. Most "contraindications" in the published literature are relative, meaning they reflect the limits of lower-volume programs, not the limits of the procedure itself. Cases that would be declined elsewhere are frequently approachable at a high-volume center with the right pre-operative planning and a well-informed patient. Nuanced cases are always discussed individually at consultation.
Patients with benign thyroid nodules recommended for surgery—whether due to size, compressive symptoms, overactive function, or indeterminate biopsy results—represent the largest and most straightforward group of candidates. Straightforward candidates typically have:
Cases that require individualized discussion—but are not automatic disqualifications—include substernal goiter (degree matters), larger gland volume, prior neck surgery, prior external beam radiation to the neck, active dental infection (a temporary factor; treat and reassess), and certain anatomical variations. A consultation is the right place to explore these.
"If you were told you need thyroid surgery, and no one mentioned the option of doing it without a neck scar, you may simply not have been seen by someone who offers it."
This is the question patients and referring physicians ask most often—and the answer surprises many people. Select patients with thyroid cancer are excellent candidates for "scarless" surgery. The international evidence, including data from high-volume centers in the United States, South Korea, Italy, and Thailand, consistently demonstrates that oncologic outcomes for appropriately selected thyroid cancer patients undergoing TOETVA are equivalent to conventional surgery. The same holds true for patients with an indeterminate result - those who think they might have cancer but aren't sure.
The ideal thyroid cancer candidate for "scarless" surgery has low- to intermediate-risk papillary thyroid carcinoma confined to the thyroid, without confirmed lateral neck lymph node metastasis (N1b). Cases involving lateral neck disease, extrathyroidal extension, or aggressive histologic variants require individualized discussion—not automatic exclusion. The diagnosis of thyroid cancer alone should never end this conversation.
→ Thyroid Cancer: Diagnosis, Staging and Surgical Options at the Russell Center
Primary hyperparathyroidism—a condition where one or more parathyroid glands become overactive, driving calcium levels dangerously high—is cured by surgery in more than 97% of cases. Most published criteria for "scarless" parathyroid surgery candidacy were written by authors operating at low-to-moderate volume, and they reflect the limits of their practice—not the limits of the procedure. At the Russell Center, we evaluate each patient individually.
Straightforward candidates typically have:
Cases that require individualized discussion—but are not automatic disqualifications—include multi-gland disease or parathyroid hyperplasia, family history or hereditary disease (MEN1, MEN2A, FIHP), lithium-associated hyperparathyroidism, prior neck surgery, prior external beam radiation to the neck, equivocal localization imaging, and re-operative parathyroid disease.
"Multi-gland disease, family history, prior radiation—these are reasons to have a longer conversation, not reasons to close the door. What disqualifies a patient at most centers is a starting point for discussion at ours."
A well-informed patient who understands the additional complexity of their case—and who chooses a surgeon with the experience to navigate it—can often still achieve a "scarless" result. The critical requirements are rigorous pre-operative localization, real-time intraoperative PTH monitoring, and a surgeon who is as comfortable with four-gland exploration as with targeted adenomectomy.
→ Hyperparathyroidism and Parathyroid Surgery at the Russell Center
A growing number of patients who pursue thyroid or parathyroid surgery are asking a question that would have seemed unusual a decade ago: Can my neck look better after surgery than it did before?
The answer, for carefully selected patients, is yes.
Because remote-access techniques require establishing a surgical working space beneath the skin of the anterior neck, the same operative field that allows "scarless" thyroid removal also provides access to the platysma muscle, submental structures, and cervical soft tissues. For patients who present with both an indication for thyroid surgery and cosmetic concerns about their neck profile—excess submental tissue, platysmal banding, or loss of cervico-mental definition—these goals can sometimes be addressed together, in a single operation, by a surgeon with dual training in endocrine surgery and cervicofacial aesthetics.
The Russell Center's proprietary Thyroid Rejuvenation™ procedure combines the definitive treatment of thyroid disease with aesthetic contouring of the neck—achieving outcomes no conventional surgeon, operating through a neck incision, can offer.
→ Learn about Thyroid Rejuvenation™
"Scarless" thyroid surgery is technically demanding. The learning curve for TOETVA is steep, and outcomes in the published literature differ significantly between low-volume adopters and high-volume experts. Centers that perform fewer than 50 cases per year report higher complication rates, longer operative times, and higher conversion rates to conventional open surgery.
This dynamic explains something patients often find surprising: the same case that would be declined at one center may be entirely approachable at another. Multi-gland parathyroid disease. Prior radiation history. A larger-than-average thyroid. These factors require more—not less—surgical sophistication. When a surgeon has performed hundreds of remote-access cases, the technical hurdles that force lower-volume operators to convert to conventional surgery become manageable variations, not dealbreakers.
At the Russell Center, "scarless" thyroid and parathyroid procedures are performed exclusively by Jonathon O. Russell, MD, FACS—the #1 volume remote-access thyroid and parathyroid surgeon in the United States over the last decade, by a significant margin. Dr. Russell introduced TOETVA to the Western Hemisphere and has trained surgeons from Stanford, NYU, MD Anderson, and Harvard in the technique. He serves on the American Thyroid Association Guidelines Committee and was the 2024 president of the North American Society for Interventional Thyroidology (NASIT). Our complication profile and outcomes data are available at consultation.
→ About Jonathon O. Russell, MD, FACS — training, credentials, outcomes data, and surgical philosophy
Candidacy for "scarless" thyroid or parathyroid surgery cannot be determined from a website. It requires a clinical consultation, a review of prior imaging and pathology, and an experienced surgeon's judgment applied to your specific anatomy and diagnosis. What a website can tell you is this: if you have been diagnosed with a thyroid nodule, thyroid cancer, or hyperparathyroidism and surgery has been recommended, there is a meaningful probability that you qualify for an approach that will leave no visible scar on your neck.
The Russell Center offers consultations—in-person in Columbia, MD, or via secure telemedicine—for patients seeking a second opinion, patients newly diagnosed and exploring options, and patients referred from endocrinologists across the mid-Atlantic region and beyond. Consultations include a full clinical review, imaging review, and a direct conversation about realistic surgical options and expected outcomes.
Call (443) 333-5233 — you will speak directly with our team, not a call center. Or request a consultation online and we will call you within one business day.
In experienced hands, thyroid nodules up to 6 cm in greatest dimension are routinely addressed with remote-access "scarless" TOETVA. The more important variable is total thyroid gland volume—glands under 45–50 mL are generally manageable. Larger glands or nodules are evaluated individually; the answer is not always no.
Yes, for well-selected patients. Low- to intermediate-risk papillary thyroid carcinoma confined to the thyroid, without confirmed lateral lymph node metastasis, can be treated with "scarless" TOETVA with equivalent oncologic outcomes to conventional surgery. Thyroid cancer alone is not a reason to forgo the conversation. See our full discussion on thyroid cancer surgery.
Yes, for well-selected patients—and the definition of "well-selected" depends heavily on who is operating. In high-volume hands with rigorous intraoperative PTH monitoring, cure rates exceed 97%. Single-gland disease with clear pre-operative localization is the most straightforward case, but multi-gland disease, family history, and other traditionally "complex" presentations are evaluated individually at our center rather than automatically excluded.
Some studies say that there is actually LESS pain with "scarless" thyroid surgery especially in the short term. Most patients report mild-to-moderate discomfort in the submental region and minor lip soreness. The vast majority of TOETVA patients at the Russell Center are discharged the same day and manage post-operative discomfort with acetaminophen and ibuprofen.
Prior conventional neck surgery is a relative—not absolute—contraindication. This is assessed individually at consultation.
The Russell Center works with insurance differently, giving our patients direct access to the specialist of their choice without referral barriers. Most patients will have some coverage of their "scarless" thyroid or parathyroid surgery. Many patients also use HSA/FSA funds. See our payment plans or contact us directly.
World-class thyroid/parathyroid health and surgery center located in the greater DC/Baltimore area.